HIV News and Research

RSS

More-is-better approach appears to improve vaccine protection from HIV-like virus in monkeys

Building on insights from an HIV vaccine regimen in humans that had partial success during a phase 3 clinical trial in Thailand, a Duke-led research team used a more-is-better approach in monkeys that appeared to improve vaccine protection from an HIV-like virus.

8 Jun 2017

Timing of girl's first menstruation may affect sexual encounter, pregnancy, and childbirth

The timing of a girl's first menstruation may affect her first sexual encounter, first pregnancy, and her vulnerability to some sexually transmitted infections, according to a meta-analysis by researchers at Columbia University Mailman School of Public Health.

8 Jun 2017

Opioid use gradually increases few years after bariatric surgery, study shows

While the proportion of adults with severe obesity using prescription opioids initially declines in the months after bariatric surgery, it increases within a matter of years, eventually surpassing pre-surgery rates of patients using the potentially addictive pain medications, according to new research from a National Institutes of Health -funded multicenter study led by the University of Pittsburgh Graduate School of Public Health.

6 Jun 2017

Research shows new Zika virus vaccine that offers 100% protection in mice

Research presented by Farshad Guirakhoo, Ph.D., Chief Scientific Officer, GeoVax, Inc., at the ASM Microbe 2017 meeting showed a new Zika virus vaccine that gives 100% protection in mice.

5 Jun 2017

CDC warning on Salmonella infections in humans from backyard poultry

CDC and other U.S health services are investigating eight multistate outbreaks of human Salmonella infections linked to contact with poultry living in the backyards.

5 Jun 2017

Early study of experimental vaccine shows escalating immune response in patients with sarcoma

The critical component of an experimental vaccine led to an escalating immune response in patients with sarcoma, an indicator of its potential anti-cancer effects.

2 Jun 2017

TSRI study reveals first-ever structure of Lassa virus protein

Before Ebola virus ever struck West Africa, locals were already on the lookout for a deadly pathogen: Lassa virus. With thousands dying from Lassa every year - and the potential for the virus to cause even larger outbreaks- researchers are committed to designing a vaccine to stop it.

1 Jun 2017

Tobacco use more common among HIV positive individuals, York study shows

Researchers at the University of York have shown that tobacco use is more common among HIV positive individuals than HIV negative individuals.

1 Jun 2017

Supportive housing linked to improvements in health of formerly homeless people with HIV/AIDS

Ask Elizabeth Bowen about the intersection of homelessness and HIV/AIDS in the United States and she'll respond without hesitation, "Housing equals health."

1 Jun 2017

HPV infection more likely to develop into cervical pre-cancer in women with HIV

A study of Senegalese women showed that human papillomavirus (HPV) infection was more likely to develop into cervical pre-cancer in women living with human immunodeficiency virus.

1 Jun 2017

Experimental drug increases progression-free survival in pancreatic cancer patients, clinical trial shows

By adding an experimental drug to a standard chemotherapy regimen, a subset of patients with metastatic pancreatic cancer had a significantly longer period before the cancer progressed as compared with those who received the standard treatment, according to a Phase 2 clinical trial led by an investigator at Fred Hutchinson Cancer Research Center.

1 Jun 2017

Phase 2 clinical study examines Alzheimer's disease drug to treat adults with Down syndrome

A phase 2 clinical trial in young adults with Down syndrome of a drug being investigated for the treatment of Alzheimer's disease supports further investigation of its potential.

1 Jun 2017

MGH scientists show how Shigella survives journey from mouth to the colon

Surviving the treacherous journey through the human body from the mouth to the colon takes a special kind of bacterial pathogen.

31 May 2017

Many cancer patients' ED visits could be avoided with better symptom management, timely care

As many as 53 percent of cancer patients' Emergency Department visits that do not require admission could be avoided with better symptom management and greater availability of outpatient care tailored to their needs, according to a new study from Fred Hutchinson Cancer Research Center.

31 May 2017

Scientists could be one step closer to developing vaccines against viruses

Scientists could be one step closer to developing vaccines against viruses such as Zika, West Nile or HIV, according to Penn State College of Medicine researchers.

31 May 2017

Small clinical trial reveals promising results of triple immunotherapy in treating rare skin cancer

Three out of four patients treated with an experimental combination of three different therapies for the rare skin cancer known as Merkel cell carcinoma are in complete remission following the treatment, according to study results from a small clinical trial led at Fred Hutchinson Cancer Research Center.

31 May 2017

Majority of adolescent girls in conflict settings are victimized by violence, study reveals

A majority of displaced adolescent girls are victimized by violence, according to a new study in the Democratic Republic of Congo and Ethiopia by researchers at Columbia University's Mailman School of Public Health.

30 May 2017

Scientists create a faster, less labor-intensive test to detect “hidden” HIV

The search to develop a HIV cure has long been overwhelmed by a seemingly simple question: How do physicians find out if somebody is cured? The virus has an ability to lie dormant in immune cells at levels that could not be detected to all, however, the most expensive and time-consuming tests can find the hidden virus.

30 May 2017

Scripps scientists make important advance in HIV vaccine design

Scientists at The Scripps Research Institute (TSRI) have made another important advance in HIV vaccine design. The development was possible thanks to previous studies at TSRI showing the structures of a protein on HIV’s surface, called the envelope glycoprotein. The scientists used these structures to design a mimic of the viral protein from a different HIV subtype, subtype C, which is responsible for the majority of infections worldwide.

29 May 2017

Dual therapy effective as second-line treatment for patients infected by HIV with multiple mutations

ANRS 12286 MOBIDIP, a clinical trial running in parallel in three countries in sub-Saharan Africa (Cameroon, Burkina Faso, and Senegal), shows that dual therapy with lamivudine and a boosted protease inhibitor is effective as second-line treatment in patients infected by HIV with multiple mutations.

29 May 2017

HIV News and Research

More-is-better approach appears to improve vaccine protection from HIV-like virus in monkeys

Timing of girl's first menstruation may affect sexual encounter, pregnancy, and childbirth

Opioid use gradually increases few years after bariatric surgery, study shows

Research shows new Zika virus vaccine that offers 100% protection in mice

CDC warning on Salmonella infections in humans from backyard poultry

Early study of experimental vaccine shows escalating immune response in patients with sarcoma

TSRI study reveals first-ever structure of Lassa virus protein

Tobacco use more common among HIV positive individuals, York study shows

Supportive housing linked to improvements in health of formerly homeless people with HIV/AIDS

HPV infection more likely to develop into cervical pre-cancer in women with HIV

Experimental drug increases progression-free survival in pancreatic cancer patients, clinical trial shows

Phase 2 clinical study examines Alzheimer's disease drug to treat adults with Down syndrome

MGH scientists show how Shigella survives journey from mouth to the colon

Many cancer patients' ED visits could be avoided with better symptom management, timely care

Scientists could be one step closer to developing vaccines against viruses

Small clinical trial reveals promising results of triple immunotherapy in treating rare skin cancer

Majority of adolescent girls in conflict settings are victimized by violence, study reveals

Scientists create a faster, less labor-intensive test to detect “hidden” HIV

Scripps scientists make important advance in HIV vaccine design

Dual therapy effective as second-line treatment for patients infected by HIV with multiple mutations

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News